Literature DB >> 16047666

Evaluation of plasma catecholamine and serum cortisol concentrations in horses with colic.

Kenneth W Hinchcliff1, Bonnie R Rush, James W Farris.   

Abstract

OBJECTIVE: To evaluate plasma epinephrine and norepinephrine concentrations and serum cortisol concentration in horses with colic and assess the relationship of these variables with clinical signs, routinely measured clinicopathologic variables, and outcome in affected horses.
DESIGN: Prospective observational study. ANIMALS: 35 horses with colic. PROCEDURE: Blood samples were collected within 30 minutes of arrival at the veterinary hospital from horses referred because of colic. Plasma and serum samples were analyzed for cortisol, epinephrine, norepinephrine, lactate, and electrolyte concentrations and acid-base variables. Heart rate at admission and outcome (survival or nonsurvival) were recorded. Univariate logistic regression was used to calculate crude (unadjusted) odds ratios and 95% confidence intervals.
RESULTS: Of the 35 horses with colic, 26 survived. Higher plasma epinephrine, plasma lactate, and serum cortisol concentrations were significantly associated with increased risk of nonsurvival, but plasma norepinephrine concentration was not associated with outcome. Plasma epinephrine concentration was significantly correlated with heart rate (r = 0.68), plasma lactate concentration (r = 0.87), blood pH (r = -0.83), anion gap (r = 0.74), and base excess (r = -0.81). CONCLUSIONS AND CLINICAL RELEVANCE: The risk of death appears to be greater in colic-affected horses with high circulating concentrations of epinephrine and cortisol. The correlation of epinephrine with other biochemical markers of illness severity and with heart rate indicates that the degree of sympathetic activation in horses with colic can be inferred from routinely measured variables.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16047666     DOI: 10.2460/javma.2005.227.276

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  7 in total

1.  Plasma serotonin in horses undergoing surgery for small intestinal colic.

Authors:  Sara C Torfs; An A Maes; Catherine J Delesalle; Bart Pardon; Siska M Croubels; Piet Deprez
Journal:  Can Vet J       Date:  2015-02       Impact factor: 1.008

2.  Adrenocorticotropic hormone stimulation tests in healthy foals from birth to 12 weeks of age.

Authors:  David M Wong; Dai Tan Vo; Cody J Alcott; Allison J Stewart; Anna D Peterson; Brett A Sponseller; Walter H Hsu
Journal:  Can J Vet Res       Date:  2009-01       Impact factor: 1.310

3.  Glucocorticoid receptor density and binding affinity in healthy horses and horses with systemic inflammatory response syndrome.

Authors:  C J Hoffman; H C McKenzie; M O Furr; A Desrochers
Journal:  J Vet Intern Med       Date:  2015 Mar-Apr       Impact factor: 3.333

4.  Blood glucose is unlikely to be a prognostic biomarker in acute colitis with systemic inflammatory response syndrome in Thoroughbred racehorses.

Authors:  Shuntaro Urayama; Daisuke Arima; Fumiaki Mizobe; Yuta Shinzaki; Motoi Nomura; Yohei Minamijima; Kanichi Kusano
Journal:  J Equine Sci       Date:  2018-03-23

5.  Cortisol and adrenocorticotropic hormone concentrations in horses with systemic inflammatory response syndrome.

Authors:  Allison J Stewart; Eileen Hackett; Francois-Rene Bertin; Taylor J Towns
Journal:  J Vet Intern Med       Date:  2019-09-12       Impact factor: 3.333

6.  Performance of predictive models of survival in horses undergoing emergency exploratory laparotomy for colic.

Authors:  Rebecca C Bishop; Santiago D Gutierrez-Nibeyro; Matthew C Stewart; Annette M McCoy
Journal:  Vet Surg       Date:  2022-06-08       Impact factor: 1.618

7.  Salivary alpha-amylase activity and cortisol in horses with acute abdominal disease: a pilot study.

Authors:  María Dolores Contreras-Aguilar; Damián Escribano; María Martín-Cuervo; Fernando Tecles; Jose Joaquín Cerón
Journal:  BMC Vet Res       Date:  2018-05-10       Impact factor: 2.741

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.